Tus kws kho mob
QP59-20 MHCP Pharmacy Benefit Exclusion for DurystaTM and Fensolvi®
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 08, 2020
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2451 - 2460 ntawm 3685
Tus kws kho mob
QP60-20 Commercial Pharmacy Benefit Exclusion for Procysbi® Delayed-Release Granules
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 08, 2020
Tus kws kho mob
P51-20 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 01, 2020
Tus kws kho mob
P63-20 Prior Authorization Updates for Skilled Nursing Facility Admissions
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 03, 2020
Tus kws kho mob
P55-20 New Prior Authorization Timeframes Required by Legislation
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 03, 2020
Tus kws kho mob
P58-20 Hereditary Angioedema (HAE) Drug Prior Authorization Management Changes for generic Icatibant, Firazyr, Haegarda, and Takhzyro — Effective October 5, 2020
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 03, 2020
Tus kws kho mob
QP62-20 Medicaid Sleep Management – Home Sleep Studies
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 22, 2020
Tus kws kho mob
QP67-20 Commercial Pharmacy Benefit Exclusion for DurystaTM, Iluvien®, Retisert® and Yutiq®
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 22, 2020
Tus kws kho mob
QP63-20 MDH Guidance to Support Hospital Patients with Disabilities and Pediatric Patients
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 22, 2020
Tus kws kho mob
2020 July Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 01, 2020